Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Bevacizumab in Trabeculectomy
NCT01263834Phase 3Completed
- Sponsor
- Prince of Songkla University
- Start
- Dec 2010
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in primary open-angle glaucoma (POAG), sponsored by Prince of Songkla University. Started Dec 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT01263834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263834.